This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Loop Capital analyst Mark Schappel initiated coverage on Palantir Technologies Inc. PLTR with a Buy rating and announced a price target of $141. Palantir shares closed at $112.06 on Wednesday. See how other analysts view this stock.
Canaccord Genuity analyst Whitney Ijem initiated coverage on Palvella Therapeutics, Inc. PVLA with a Buy rating and announced a price target of $39. Palvella Therapeutics shares closed at $20.97 on Wednesday. See how other analysts view this stock.
Citigroup analyst Yigal Nochomovitz initiated coverage on Candel Therapeutics, Inc. CADL with a Buy rating and announced a price target of $25. Candel Therapeutics shares closed at $10.47 on Wednesday. See how other analysts view this stock.
Baird analyst Jeff Johnson initiated coverage on Beta Bionics, Inc. BBNX with a Neutral rating and announced a price target of $20. Beta Bionics shares closed at $21.81 on Wednesday. See how other analysts view this stock.
B. Riley Securities analyst Kyle Bauser initiated coverage on Electromed, Inc. ELMD with a Buy rating and announced a price target of $38. Electromed shares closed at $28.54 on Wednesday. See how other analysts view this stock.